Why Team Trump is wrong about Carter Page, the dossier and

New Post Public Reply Private Reply Replies (1) Message Board

Aug 22, 2018 at 10:45 AM 158

Quote:

Why Team Trump is wrong about Carter Page, the dossier and that secret warrant

Mueller's Russia probe wasn't launched because of Carter Page, and the dossier compiled by an ex-spy was only part of the evidence cited to get a warrant.

by Ken Dilanian / Jul.23.2018 / 5:11 PM ET

WASHINGTON — President Donald Trump and his allies are claiming that the partial contents of a secret national security "FISA" warrant, released Saturday, vindicate their claim that special counsel Robert Mueller's Russia investigation was improperly launched on the basis of a speculative opposition research document paid for by Democrats.

The Trump camp says the probe has its roots in the "Trump dossier" compiled by former British spy Christopher Steele, which alleges collusion between the Trump campaign and Russia.

"So we now find out that it was indeed the unverified and Fake Dirty Dossier, that was paid for by Crooked Hillary Clinton and the DNC, that was knowingly & falsely submitted to FISA and which was responsible for starting the totally conflicted and discredited Mueller Witch Hunt!" the president wrote in a tweet Monday morning.

Trump also continues to suggest that the electronic surveillance of his one-time campaign aide, Carter Page, which was authorized by the FISA warrant, launched the Russia probe.

Both of these assertions are false.

Here is why.

The Russia investigation wasn't launched because of Carter Page.
The heavily redacted documents released Saturday comprise an application to, and subsequent renewals by, judges on the Foreign Intelligence Surveillance Court allowing the FBI to investigate Page, a foreign policy aide to the Trump campaign.

But it's already been established by the House Intelligence Committee that the Russia investigation began after the FBI learned that another campaign aide, George Papadopoulos, had been approached by a Russian agent.

The agent told Papadopoulos the Russians had incriminating information about Hillary Clinton, including emails, according to court documents.. Papadopoulos then mentioned to an Australian diplomat that the Russians had "dirt" on Clinton, the Australians contacted the U.S. government, and the FBI began to take a look.

The so-called dossier formed only a smart part of the evidence used to meet the legal burden of establishing "probable cause" that Page was an agent of Russia.

The released documents contain dozens of pages that are entirely blacked out. People who have read them, including Rep. Adam Schiff, the ranking Democrat on the House Intelligence Committee, say they contain secret evidence establishing ties between Page and Russians — evidence that goes beyond what was included in the dossier compiled by Christopher Steele.

Frank Figliuzzi, the former FBI counterintelligence chief who is now an NBC News contributor, says that likely includes reporting from human sources and intercepted communications. Page, it should be said, denies that he was an agent of Russia and has not been charged with a crime.

National security experts who have reviewed the document say that even the parts that aren't blacked out contain more than enough information to provide a judge reason to rule that the FBI had probable cause to believe that Page was an agent of Russia.

Probable cause is much lower than the reasonable doubt the standard required to convict someone of a crime. "It's the probability of a possibility," said William Banks, director of the Institute for National Security and Counterterrorism at Syracuse University College of Law. Page had already appeared on the FBI's radar as a target of Russian intelligence recruitment in a separate spy case.

He has acknowledged that he traveled to Moscow and met with Russian officials during the 2016 campaign. It would have been malpractice for the FBI, confronted with allegations that Page was helping the Russians, not to investigate, Figliuzzi says.

Four different judges, all appointed by Republican presidents, signed off on electronic surveillance of Carter Page.

And that's the end of a long process that involves multiple layers of review within the FBI and the Justice Department, current and former officials say. Anyone trying to put one over on the FISA court would be risking his or her career.

It was not improper — and perfectly normal — for the FBI to disclose information from the Steele dossier as part of the warrant application.
Andrew McCarthy, a former prosecutor and Trump backer, has argued that the dossier amounted to unverified hearsay, and that the FBI misrepresented that it had verified the information.

But Figliuzzi and other former officials say the use of hearsay is common in warrant applications, because the FBI wants to tell the judge as much as possible about what is known about the target. No judge, however, would grant a surveillance warrant based entirely on hearsay, Figliuzzi said.

The FBI disclosed to the court that Steele was paid by people seeking to discredit Trump. But the FBI viewed Steele as credible.
"They dealt with the Steele stuff in an extensive footnote with bolded language," Banks said.

The note didn't disclose that the dossier was paid for by Democrats because the document didn't use any names or identities. It called Trump "Candidate 1" even after he was elected president. But the note did say that the dossier appeared to be funded by people seeking to discredit Trump.

In addition, Steele was seen not as a partisan operative, but as a credible source, according to the warrant. The document doesn't say this, but Steele had helped the FBI for years, including providing crucial information in the U.S. investigation of corruption in international soccer

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...